HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION
Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer'...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DIAMANITIS, GEORGE MOORE, WILLIAM JAY STOCK, JOSEPH RAYMOND KREFT, ANTHONY FRANK WOLLER, KEVIN ROGER CASEBIER, DAVID SCOTT COLE, DEREK CECIL KURBRAK, DENNIS MICHAEL KUTTERER, KRISTINA MARTHA |
description | Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE60121032TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE60121032TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE60121032TT23</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAsDqL-Q-geaFNwT5OrOUxzklyHTqVInEQL9f9x8QOc3vL24uKBIZGdbMBsPcg8hp6iGdCBNCFLjB47ZEoQpYMkO2CjzDAFQqduidx4ZaR4FLvH8tzK6edBVD2w9aqs77ls63Ivr_KZHZzrRjd1q5l1-1f6AmJYLY8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION</title><source>esp@cenet</source><creator>DIAMANITIS, GEORGE ; MOORE, WILLIAM JAY ; STOCK, JOSEPH RAYMOND ; KREFT, ANTHONY FRANK ; WOLLER, KEVIN ROGER ; CASEBIER, DAVID SCOTT ; COLE, DEREK CECIL ; KURBRAK, DENNIS MICHAEL ; KUTTERER, KRISTINA MARTHA</creator><creatorcontrib>DIAMANITIS, GEORGE ; MOORE, WILLIAM JAY ; STOCK, JOSEPH RAYMOND ; KREFT, ANTHONY FRANK ; WOLLER, KEVIN ROGER ; CASEBIER, DAVID SCOTT ; COLE, DEREK CECIL ; KURBRAK, DENNIS MICHAEL ; KUTTERER, KRISTINA MARTHA</creatorcontrib><description>Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described.</description><language>ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070111&DB=EPODOC&CC=DE&NR=60121032T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070111&DB=EPODOC&CC=DE&NR=60121032T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DIAMANITIS, GEORGE</creatorcontrib><creatorcontrib>MOORE, WILLIAM JAY</creatorcontrib><creatorcontrib>STOCK, JOSEPH RAYMOND</creatorcontrib><creatorcontrib>KREFT, ANTHONY FRANK</creatorcontrib><creatorcontrib>WOLLER, KEVIN ROGER</creatorcontrib><creatorcontrib>CASEBIER, DAVID SCOTT</creatorcontrib><creatorcontrib>COLE, DEREK CECIL</creatorcontrib><creatorcontrib>KURBRAK, DENNIS MICHAEL</creatorcontrib><creatorcontrib>KUTTERER, KRISTINA MARTHA</creatorcontrib><title>HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION</title><description>Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAsDqL-Q-geaFNwT5OrOUxzklyHTqVInEQL9f9x8QOc3vL24uKBIZGdbMBsPcg8hp6iGdCBNCFLjB47ZEoQpYMkO2CjzDAFQqduidx4ZaR4FLvH8tzK6edBVD2w9aqs77ls63Ivr_KZHZzrRjd1q5l1-1f6AmJYLY8</recordid><startdate>20070111</startdate><enddate>20070111</enddate><creator>DIAMANITIS, GEORGE</creator><creator>MOORE, WILLIAM JAY</creator><creator>STOCK, JOSEPH RAYMOND</creator><creator>KREFT, ANTHONY FRANK</creator><creator>WOLLER, KEVIN ROGER</creator><creator>CASEBIER, DAVID SCOTT</creator><creator>COLE, DEREK CECIL</creator><creator>KURBRAK, DENNIS MICHAEL</creator><creator>KUTTERER, KRISTINA MARTHA</creator><scope>EVB</scope></search><sort><creationdate>20070111</creationdate><title>HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION</title><author>DIAMANITIS, GEORGE ; MOORE, WILLIAM JAY ; STOCK, JOSEPH RAYMOND ; KREFT, ANTHONY FRANK ; WOLLER, KEVIN ROGER ; CASEBIER, DAVID SCOTT ; COLE, DEREK CECIL ; KURBRAK, DENNIS MICHAEL ; KUTTERER, KRISTINA MARTHA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE60121032TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DIAMANITIS, GEORGE</creatorcontrib><creatorcontrib>MOORE, WILLIAM JAY</creatorcontrib><creatorcontrib>STOCK, JOSEPH RAYMOND</creatorcontrib><creatorcontrib>KREFT, ANTHONY FRANK</creatorcontrib><creatorcontrib>WOLLER, KEVIN ROGER</creatorcontrib><creatorcontrib>CASEBIER, DAVID SCOTT</creatorcontrib><creatorcontrib>COLE, DEREK CECIL</creatorcontrib><creatorcontrib>KURBRAK, DENNIS MICHAEL</creatorcontrib><creatorcontrib>KUTTERER, KRISTINA MARTHA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DIAMANITIS, GEORGE</au><au>MOORE, WILLIAM JAY</au><au>STOCK, JOSEPH RAYMOND</au><au>KREFT, ANTHONY FRANK</au><au>WOLLER, KEVIN ROGER</au><au>CASEBIER, DAVID SCOTT</au><au>COLE, DEREK CECIL</au><au>KURBRAK, DENNIS MICHAEL</au><au>KUTTERER, KRISTINA MARTHA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION</title><date>2007-01-11</date><risdate>2007</risdate><abstract>Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | ger |
recordid | cdi_epo_espacenet_DE60121032TT2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | HETEROCYCLISCHE SULFONAMIDE ALS INHIBITOREN DER BETA-AMYLOID-PRODUKTION |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A52%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DIAMANITIS,%20GEORGE&rft.date=2007-01-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE60121032TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |